Background -Essential hyperhidrosis is characterised by an overactivity of the sympathetic fibres passing through the upper dorsal sympathetic ganglia D2-D3. Anatomical interruption at the D2-D3 level is a highly effective treatment for essential hyperhidrosis but also causes (partial) cardiac denervation and, after surgical sympathicolysis, important impairment of cardiopulmonary exercise function has been observed. The purpose of this study was to compare the results of cardiopulmonary exercise testing between patients with essential hyperhidrosis and a normal control population, and to examine the effects of thoracoscopic D2-D3 sympathicolysis on cardiopulmonary exercise capacity in patients with essential hyperhidrosis. Methods -Maximal, symptom limited incremental exercise tests were performed in 26 patients with severe essential hyperhidrosis one week before and one month after D2-D3 thoracoscopic sympathicolysis, and in 14 age and sex matched healthy volunteers. D2-D3 thoracosopic sympathicolysis was performed using a simplified one stage bilateral procedure. Results -Palmar hyperhidrosis was relieved in every patient, confirming the D2-D3 denervation. A higher peak heart rate (7%) was seen in the patient group than in the normal subjects, but all other cardiovascular, metabolic, and respiratory parameters were similar. After D2-D3 thorascopic sympathicolysis, heart rate at rest (13%) and at peak exercise (7%) were reduced, together with an increase in oxygen pulse. All The exact cause is unknown, although overactivity of the sympathetic fibres which pass through the dorsal sympathetic ganglia D2 (and D3) has been noted.56 Interruption of the sympathetic chain at the D2-D3 level (preferably by thoracoscopic intervention) is an effective and safe treatment for essential hyperhidrosis refractory to conventional local, systemic, or other treatment.47"' However, the D2 and D3 ganglia are also in the direct pathway of sympathetic innervation ofthe heart.'0 Interruption of the upper dorsal sympathetic chain has been suggested as treatment for several cardiac disorders -for example, angina pectoris, ventricular tachycardia, and arrythmias associated with the long QT syndrome." Surgical D2-D3 sympathectomy for essential hyperhidrosis induces important cardiopulmonary impairment. After surgical excision of the D2-D3 ganglia via the supraclavicular approach, 30% of patients were unable to perform a maximal exercise test due to dyspnoea, fatigue, or dizziness. In order to study the autonomic (dys)function relative to cardiopulmonary function in patients with essential hyperhidrosis, and to study the effects of upper dorsal thoracoscopic sympathicolysis on cardiopulmonary function during exercise, exercise testing was performed on 26 patients with essential hyperhidrosis before and one month after bilateral D2-D3 thoracoscopic sympathicolysis, and in 14 age and sex matched healthy volunteers.
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Background -Essential hyperhidrosis is characterised by an overactivity of the sympathetic fibres passing through the upper dorsal sympathetic ganglia D2-D3. Anatomical interruption at the D2-D3 level is a highly effective treatment for essential hyperhidrosis but also causes (partial) cardiac denervation and, after surgical sympathicolysis, important impairment of cardiopulmonary exercise function has been observed. The purpose of this study was to compare the results of cardiopulmonary exercise testing between patients with essential hyperhidrosis and a normal control population, and to examine the effects of thoracoscopic D2-D3 sympathicolysis on cardiopulmonary exercise capacity in patients with essential hyperhidrosis. Methods -Maximal, symptom limited incremental exercise tests were performed in 26 patients with severe essential hyperhidrosis one week before and one month after D2-D3 thoracoscopic sympathicolysis, and in 14 age and sex matched healthy volunteers. D2-D3 thoracosopic sympathicolysis was performed using a simplified one stage bilateral procedure. Results -Palmar hyperhidrosis was relieved in every patient, confirming the D2-D3 denervation. A higher peak heart rate (7%) was seen in the patient group than in the normal subjects, but all other cardiovascular, metabolic, and respiratory parameters were similar. After D2-D3 thorascopic sympathicolysis, heart rate at rest (13%) and at peak exercise (7%) were reduced, together with an increase in oxygen pulse. All Essential hyperhidrosis is characterised by excessive sweating of the palms of the hands and often the soles of the feet and the armpits."4
The exact cause is unknown, although overactivity of the sympathetic fibres which pass through the dorsal sympathetic ganglia D2 (and D3) has been noted. 8 7) years (range 14-44 years) were studied. All suffered from severe hyperhidrosis of the hands and some the feet (82%) and armpits (65%), which was refractory to local, systemic and/or iontophoretic treatment. Physical examination was otherwise normal, and there was no history of cardiovascular or pulmonary disease. No patient was treated with cardiopulmonary medication. All patients gave informed consent to the study. Patients were studied one week before and one month after sympathicolysis. Breath-by-breath gas analysis was performed using a zirconium oxygen analyser and an infrared absorption carbon dioxide analyser which were calibrated daily. Air flows were measured with a thermal conductivity mass flow meter which was calibrated before every test. All data were continuously recorded, stored, and analysed by the 2900 Sensor Medics software package. The parameters measured are given in the results section and shown in the tables.
THORACOSCOPIC SYMPATHICOLYSIS
All interventions were performed under strict aseptic conditions in a fully equipped operating theatre, using general anaesthesia. Intubation was performed with a Hi-Lo jet endotracheal tube (Mallinckrodt) and ventilation was assured using high frequency jet ventilation (Acutronic) on both lungs.
After creation of a right pneumothorax a 7 mm trocar was introduced into the pleural cavity through the second intercostal space. The thoracoscope (Richard Wolf, Knitlingen, Germany) was introduced via the trocar, and the dorsal sympathetic chain was identified. An insulated biopsy forceps, connected to a unipolar coagulation unit, was then introduced via a second trocar, under direct vision. The sympathetic trunk was identified and transected at the second and third dorsal rib heads, using 5-15 bursts of 60 watts. After re-expansion of the pneumothorax and skin closure, the same procedure was performed on the other side. Mean duration of this bilateral procedure was about 25 minutes (range 
Results
In all patients, palmar hyperhidrosis was relieved by the intervention, confirming complete D2-D3 denervation. All control subjects and all patients successfully completed a maximal exercise test before and after symnpathicolysis and the results are summarised in tables 1 and 2.
In basal resting conditions there were no significant differences between controls and patients before treatment, although heart rate and oxygen pulse tended to be lower in the patients (table 1) . Peak exercise heart rate was significantly higher in the patients before treatment than in the controls: 180-6 (12-9) versus 168-3 (15-9) bpm (p<005), although this difference did not reach statistical significance when expressed as percentage predicted. There were no differences in cardiovascular (blood pressure), ventilatory or metabolic parameters, nor in the subjective reasons for cessation of exercise.
Pairwise data analysis in the patients before and after sympathicolysis showed a significant decrease in resting and maximal heart rate, and an increase in oxygen pulse. These postoperative values are not statistically different from the data obtained in normal volunteers. All other parameters, including the subjective reasons for cessation of exercise, remained unchanged after sympathicolysis.
Discussion
We have compared cardiopulmonary exercise testing in healthy controls and hyperhidrotic patients, and in these patients before and after thoracoscopic D2-D3 sympathicolysis. Thoracoscopic sympathicolysis had no influence on exercise capacity nor on the ventilatory response to exercise, and only minimal effects on the cardiac response to exercise.
Essential hyperhidrosis is probably caused by increased activity of the sympathetic fibres which pass through the D2 and D3 dorsal sympathetic ganglia. It causes autonomic dysfunction with less reflex bradycardia in response to the Valsalva manoeuvre or facial immersion, a higher degree of cutaneous vasoconstriction in response to finger (or cold) immersion,5 and a reduction in cholinomimetic-induced hypothermia. 6 Our results suggest that the overactivity of the sympathetic nervous system in the patients has a very small effect only on the integrated cardiorespiratory metabolic function at rest, and a moderate effect at maximal exercise. This is in agreement with the fact that, in the resting state (when the stress on the cardiovascular system is minimal), heart rate is mainly under vagal restraint,'3 whereas during exercise an increase in heart rate occurs through a simultaneous decrease in vagal activity and an increase in sympathetic activity.'1'5 The sympathetic overactivity in patients with essential hyperhidrosis therefore seems to exert its effect mainly in conditions of sympathetic activation.
After sympathicolysis the heart rate at rest was significantly reduced, confirming that in these patients resting heart rate is (at least partially) also under sympathetic control. More important changes have been reported by Papa et all6 who observed a decrease of 16% in resting heart rate and 18% in maximal heart rate after bilateral surgical (supraclavicular approach) D2 and D3 sympathectomy. Furthermore, about 30% of their patients were unable to complete the postoperative exercise test because of weakness, dyspnoea, dizziness, or general fatigue at submaximal levels of work. These dramatic changes were not seen in our patients, probably because thoracoscopic sympathicolysis offers a far more accurate and precise interruption of the sympathetic chain4 and because the procedure causes less effect on lung volumes and airflow rates than conventional surgery. '7 18 Our findings are comparable with the effects of sympathectomy performed in patients with various cardiovascular disorders -for example, paroxysmal atrial tachycardia, angina, and hypertension. Bilateral D2-D5 sympathectomy decreasing the heart rate from 8% to 28-9% at rest and from 21-8% to 31-9% during exercise have been observed.619 Similarly, after medical P receptor blockade only small decreases in heart rate occur at rest, but greater reductions occur at maximal exercise. 15 '9 20After P receptor blockade cardiac output is maintained by a parallel increase in stroke volume through the Frank-Starling mechanism2' which may explain the increase in oxygen pulse seen in our patients after sympathicolysis. Finally, similar findings have been observed after acute epidural sympathetic denervation by a sensory block of C4-D7: mean resting heart rate significantly dropped from 66 to 58 beats per minute.22 D2-D3 sympathicolysis in patients with essential hyperhidrosis had no effect on ventilatory and metabolic parameters, in constrast to the effects of P blockade in normal subjects in whom measured oxygen uptake is slightly reduced by about 5%, and the anaerobic threshold is lowered by about 20%.2o
